[HTML][HTML] Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic review

J Slattery, N Kumar, L Delhey, M Berk, O Dean… - Neuroscience & …, 2015 - Elsevier
N-acetylcysteine (NAC) is recognized for its role in acetaminophen overdose and as a
mucolytic. Over the past decade, there has been growing evidence for the use of NAC in …

Pharmacological treatment of methamphetamine/amphetamine dependence: a systematic review

KJ Siefried, LS Acheson, N Lintzeris, N Ezard - CNS drugs, 2020 - Springer
Background Stimulant drugs are second only to cannabis as the most widely used class of
illicit drug globally, accounting for 68 million past-year consumers. Dependence on …

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

RCJ Bradlow, M Berk, PW Kalivas, SE Back… - CNS drugs, 2022 - Springer
Abstract N-acetyl-L-cysteine (NAC) is a compound of increasing interest in the treatment of
psychiatric disorders. Primarily through its antioxidant, anti-inflammatory, and glutamate …

Leaky brain in neurological and psychiatric disorders: Drivers and consequences

G Morris, BS Fernandes, BK Puri… - Australian & New …, 2018 - journals.sagepub.com
Background: The blood–brain barrier acts as a highly regulated interface; its dysfunction
may exacerbate, and perhaps initiate, neurological and neuropsychiatric disorders …

N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects

A Minarini, S Ferrari, M Galletti… - Expert Opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: N-acetylcysteine (NAC) is widely known for its role as a mucolytic
and as an antidote to paracetamol overdose. There is increasing interest in the use of NAC …

Effects of the Usage of l-Cysteine (l-Cys) on Human Health

N Clemente Plaza, M Reig García-Galbis… - Molecules, 2018 - mdpi.com
This review summarizes recent knowledge about the use of the amino acid l-Cysteine (l-
Cys) through diet, nutritional supplements or drugs with the aim to improve human health or …

Pharmacological treatments for methamphetamine addiction: current status and future directions

J Ballester, G Valentine, M Sofuoglu - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Methamphetamine (MA) abuse remains a global health challenge despite
intense research interest in the development of pharmacological treatments. This review …

Glial and neuroinflammatory targets for treating substance use disorders

RK Bachtell, JD Jones, KG Heinzerling… - Drug and alcohol …, 2017 - Elsevier
Background The plenary session at the 2016 Behavior, Biology and Chemistry:
Translational Research in Addiction Conference focused on glia as potential players in the …

N‐acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta‐analysis

MS Duailibi, Q Cordeiro, E Brietzke… - … American journal on …, 2017 - Wiley Online Library
Background and Objectives Recent neurobiological evidences along with clinical
observations justify the use of N‐acetylcysteine (NAC) as a medication for craving. The …

Pharmacotherapy for amphetamine dependence: A systematic review

NK Lee, L Jenner, A Harney, J Cameron - Drug and alcohol dependence, 2018 - Elsevier
Background Demand for treatment for amphetamine use is increasing internationally.
Establishing effective pharmacotherapy provides broader treatment options for people who …